WebCHARLESTOWN, Mass., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for patients with neuromuscular and cardiac diseases, today announced the grant of inducement awa... Web2 days ago · CHARLESTOWN, Mass. , April 13, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines …
2024-04-13 NDAQ:SLDB Press Release Solid Biosciences Inc.
WebCHARLESTOWN, Mass. and CAMBRIDGE, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), and AavantiBio, Inc., a privately-held gene therapy company focused on transforming the lives of patients with Friedreich’s … WebSLDB News Headlines Sep 30, 2024 Friday Sector Leaders: Biotechnology, Precious Metals Aug 14, 2024 Analysts Are Updating Their Solid Biosciences Inc. (NASDAQ:SLDB) … has no dwarf debug info
SLDB News: Earnings, Analyst Moves, and More - StockNews
Web2 days ago · CHARLESTOWN, Mass. , April 13, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that Bo Cumbo, President and Chief Executive Officer, will present at the 22 nd Annual Needham Healthcare Conference on … WebFind real-time SLDB - Solid Biosciences Inc stock quotes, company profile, news and forecasts from CNN Business. SLDB - Solid Biosciences Inc Stock quote - … WebApr 13, 2024 · GlobeNewswire Apr 13, 2024, 05:05 AM. CHARLESTOWN, Mass. , April 13, 2024 (GLOBE NEWSWIRE) — Solid Biosciences Inc. ( Nasdaq: SLDB ), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that Bo Cumbo, President and Chief Executive Officer, will present at the 22 nd … has no exported member named chainexpression